The UIC Embryonic Stem Cell Review Committee (ESCRO) committee reviews research proposals involving the use of human embryonic stem cells (hES). The ESCRO committee is responsible for the oversight of all hES research being conducted at or supported by UIC to ensure that it meets the National Academy of Science (NAS) guidelines. Additionally, the ESCRO committee will have the responsibility for maintaining a registry of all hES cell lines that are imported into or maintained at the UIC, including the NIH-approved hES lines.
In accordance with the NAS guidelines, the ESCRO committee includes "representatives of the public and persons with expertise in developmental biology, stem cell research, molecular biology, assisted reproduction, and ethical and legal issues in hES cell research."
On behalf of the University of Illinois at Chicago Office of Technology Management (OTM), in partnership with the Office of the Vice Chancellor for Research is opening a call for submissions for the Chancellor’s Translational Research Initiative (CTRI).